CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma
| Autor: | Michio Tani, Ko Sugiyama, Shingo Shimada, Hideki Yokoo, Akinobu Taketomi, Hirofumi Kamachi, Akihisa Nagatsu, Toshiya Kamiyama, Koichi Kato, Tatsuhiko Kakisaka, Kazuki Wakizaka, Yuki Fujii, Tatsuya Orimo, Ryosuke Matsuoka, Masafumi Ohira |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
cancer stem cells
Poor prognosis medicine.disease_cause 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Cancer stem cell Intermediate cell carcinoma parasitic diseases Medicine CD133 neoplasms combined hepatocellular cholangiocarcinoma Hepatology business.industry INT Epithelial cell adhesion molecule medicine.disease digestive system diseases Infectious Diseases chemistry 030220 oncology & carcinogenesis Hepatocellular carcinoma cardiovascular system Cancer research Immunohistochemistry 030211 gastroenterology & hepatology epithelial cell adhesion molecule business Carcinogenesis |
| Zdroj: | Hepatology research : the official journal of the Japan Society of HepatologyReferences. 50(2) |
| ISSN: | 1386-6346 |
| Popis: | Aim A new classification of combined hepatocellular cholangiocarcinoma (CHC) was recently reported. Cancer stem cells have been associated with CHC carcinogenesis. This study examined the association of cancer stem cell marker expression and prognosis in CHC classified using the new classification. Methods We enrolled 26 CHC patients and classified them according to the new classification. We evaluated the expression of cancer stem cell markers (CD56, CD133, and epithelial cell adhesion molecule [EpCAM]) by immunohistochemical staining in each component. We analyzed the association between expressions and prognosis. Results Seven cases were hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) (cHCC-CCA), 12 were HCC and intermediate cell carcinoma (HCC-INT), and seven were intermediate cell carcinoma (INT). The CD133-positive rate tended to be higher in the CCA (42.9%) and INT component (50.0%) than the HCC component (14.3%) in cHCC-CCA. In HCC-INT, the CD133-positive rate in the INT component (83.3%) was significantly higher than the HCC component (8.3%; P = 0.001). For EpCAM, the positive rate in the CCA component (71.4%) and INT component (50.0%) tended to be higher than the HCC component (14.3%) in cHCC-CCA. Overall survival and disease-free survival were significantly worse in cases with CD133-positive (P = 0.048 and P = 0.048, respectively) or EpCAM-positive (P = 0.041 and P = 0.041, respectively) CCA component in cHCC-CCA. Conclusions INT and CCA components showed higher expression rates of cancer stem cell markers than the HCC component. CD133 or EpCAM expression in the CCA component was associated with poor prognosis in cHCC-CCA. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text